SC 13G/A: TScan Therapeutics, Inc.
Ticker: TCRX · Form: SC 13G/A · Filed: 2024-11-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by TScan Therapeutics, Inc..
Risk Assessment
Risk Level: low
From the Filing
0001140361-24-046894.txt : 20241114 0001140361-24-046894.hdr.sgml : 20241114 20241114160531 ACCESSION NUMBER: 0001140361-24-046894 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241114 GROUP MEMBERS: ANUP ARORA GROUP MEMBERS: PARAG SHAH SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92700 FILM NUMBER: 241461900 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: K2 HealthVentures Equity Trust LLC CENTRAL INDEX KEY: 0001948604 ORGANIZATION NAME: IRS NUMBER: 842128131 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 855 BOYLSTON STREET STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-201-5983 MAIL ADDRESS: STREET 1: 855 BOYLSTON STREET STREET 2: 10TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 SC 13G/A 1 ef20038300_sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* TScan Therapeutics, Inc. (Name of Issuer) Voting Common Stock, $0.0001 par value per share (Title of Class of Securities) 89854M101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ). Continued on following pages Page 1 of 10 Pages Exhibit Index: Page 9 CUSIP No. 89854M101 Page  2 of 10 Pages 1 NAMES OF REPORTING PERSONS     K2 HealthVentures Equity Trust LLC         2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP     (a)☐     (b)☐     3 SEC USE ONLY               4 CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER     0         6 SHARED VOTING POWER     5,324,144 (1)         7 SOLE DISPOSITIVE POWER     0         8 SHARED DISPOSITIVE POWER     5,324,144 (1)         9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     5,324,144 (1)         10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)     ☐         11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)     9.985% (1)         12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)     OO         (1) See Items 2 and 4 CUSIP No. 89854M101 Page  3 of 10 Pages 1 NAMES OF REPORTING PERSONS     Parag Shah